In this episode Dr. Srinivas Iyengar and Dr. Kasi Ramanathan will discuss their own patient and device experiences as they relate to the evolution of Transcatheter Aortic Valve Replacement (TAVR). They review how different valves are designed and how leaflet positioning and frame attachment points are proving to impact the durability and longevity of the different transcatheter valve types differently. The physicians discuss how their perspectives have evolved with new patient indications, transitioning from an initial ‘one TAVR fits all’ mindset to their current perspective of ‘appreciating the nuances of valve durability and patient selection. Especially as it relates to providing long term success and freedom from reintervention for their lower risk and more active patients. Finally, Dr. Iyengar discusses an emerging hot topic within the TAVR community - the physiology and impact of the Neosinus created by the different TAVR designs. Listen as he dissects what the neosinus is, how it differs between valves, and what role it plays in facilitating a transcatheter valve’s circularity and durability after it has been implanted inside of an elliptical aortic annulus.

Join us in an enlightening conversation hosted by Dr. Steven Yakubov with Dr. Guilherme Attizzani, the director of the Structural Heart Program at University Hospitals in Cleveland, Ohio, and a professor of medicine at Case Western Reserve School of Medicine. Dr. Attizanni shares his inspiring journey from Brazil to becoming a leading figure in cardiology. Discover how his unique experiences and dedication have shaped his approach to post-tab coronary access and lifetime management.

In this episode, Dr. Attizzani discusses his strategic efforts to build a successful structural heart program, overcome challenges, and foster relationships with referring physicians. He highlights the importance of creating a concierge service for patients and referring doctors and emphasizes the vital role of nurse navigators in delivering exceptional care.

Dive into Dr. Attizzani's groundbreaking academic pursuits, including his work on coronary access post-TAVR implantation and innovative strategies for the lifetime management of aortic valve patients. Learn about his involvement in pivotal clinical trials and his contributions to optimizing resources and procedures in interventional cardiology.

Explore the future of aortic valve interventions as Dr. Attizzani shares his vision for enhancing coronary access, customizing procedures, and addressing the challenges of TAV-IN-TAV interventions. This episode offers valuable insights for medical professionals and anyone interested in the advancements shaping the field of cardiology.

Join Dr. Puja Parikh, Director of the TAVR program at Stony Brook University Hospital, as she hosts a captivating conversation with the renowned cardiac surgeon Dr. Michael Reardon. Dr. Reardon, a leader in cardiac surgery and structural heart innovation, shares his remarkable journey into the field, from an unexpected childhood incident to becoming a pivotal figure in the transcatheter aortic valve replacement (TAVR) revolution.

In this insightful episode, Dr. Reardon reflects on the evolution of cardiac surgery training and the transformative impact of TAVR. He discusses the importance of adapting to new technologies, the future of cardiac surgery education, and the potential challenges and opportunities facing young surgeons today. The conversation also delves into the role of AI in patient care and the ongoing advancements in valve technologies.

Dr. Reardon offers invaluable advice to early-career colleagues and trainees, emphasizing the importance of open-mindedness, hands-on experience, and collaboration between cardiologists and surgeons. This episode is a must-listen for anyone interested in the future of cardiac care and the dynamic world of structural heart interventions.

In this episode of the Structural Heart podcast, world-renowned cardiothoracic surgeons Dr. Patrick McCarthy and Dr. Dan O'Hair discuss a wide range of topics centered around advancing technology within the surgical and structural heart landscape. The episode starts with Dr. McCarthy and Dr. O'Hair discussing emerging surgical mitral technology alongside how lulls in procedures associated with the COVID-19 pandemic afforded them the extra time to analyze their own program data and better understand which patients benefited most from various cardiac therapies. Next, the conversation shifts from mitral to aortic as they discuss consistent themes and fundamentals that are shared between open-heart aortic valve replacements and transcatheter aortic valve replacements. Both physicians speak to the importance of practicing evidence-based medicine within the cardiovascular space and making decisions rooted in data regarding critical procedures like valve replacements. The episode concludes with light-hearted conversation lessons they wish they had learned earlier in their careers and want to pass along to an emerging generation of cardiovascular physicians.

Join us for an exciting discussion led by Dr Hemal Gada, an Interventional Cardiologist from UPMC,Pennsylvania, and Dr. Gilbert Tang, a Cardiac Surgeon from Mount Sinai in NY. The conversation will explore how the evolving TAVR landscape shapes Aortic Stenosis interventions. From the early days to the present, a significant number of patients have been treated, generating a wealth of data on efficiencies, PVL, Hemodynamic impact, and clinical results. What will the data reveal? Will we see a 'TAVR Tsunami' of patients or a more gradual increase in returning patients? Are there any predictors that can help us identify the right patient? What role does Neosinus flow and thrombosis play in this context? Does valve selection influence future events? How do new generations of self-expanding valves influence clinical results? This is an opportunity to analyze mid-long-term data and explore these crucial topics. What do we know about explant TAVR? These are just a few crucial topics explored in this upcoming edition of the Structural Heart Podcast. We invite you to join us for a deep dive into these issues in TAVR and Aortic Stenosis interventions.

Don't miss this crucial episode of the Structural Heart Podcast, where we dive into the SMART trial data and evaluate it from two perspectives. We're honored to be joined by cardiothoracic surgeon Dr. Dan O'Hair and one of the SMART trial's PIs, Dr. Hemal Gada. This discussion is not just about the Evolut and Sapien valve platforms but also about what this data means for patients. Stay tuned as they share their critical interpretations of the SMART Trial.

In this episode, we're going to do a deep dive into the Low-Risk TAVR trials for intra-annular Ballon Expandable and Self Expandable supra-annular, and I'm going to be joined by our special guest, Dr. Hemal Gada, renowned interventional cardiologist, and structuralist and president of the Heart and Vascular Institute atIP{MC in Harrisburg, Pennsylvania.

We're gonna cover all kinds of topics like death and stroke thrombosis whose valves are failing, and why.